A Study of E7389 in Advanced/Metastatic Breast Cancer Patients

Status:
Completed

Trial end date:
2006-11-01

Target enrollment:

Participant gender:

The purpose of this study is to determine if E7389 is a safe and effective treatment for advanced/metastatic breast cancer.

Phase 2

Eisai Inc.